Menu

Filtros : "Japão" "ACS Infectious Diseases" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors (2021)

    Okaniwa, Masanori; Aguiar, Anna Caroline Campos; Guido, Rafael Victorio Carvalho

    Source: ACS Infectious Diseases. Unidade: IFSC

    Subjects: PLASMODIUM, MALÁRIA, ANTIMALÁRICOS, ANTIPARASITÁRIOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      OKANIWA, Masanori e AGUIAR, Anna Caroline Campos e GUIDO, Rafael Victorio Carvalho. Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors. ACS Infectious Diseases, v. 7, n. 6, p. 1680-1689, 2021Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.1c00020. Acesso em: 01 out. 2024.

    • APA

      Okaniwa, M., Aguiar, A. C. C., & Guido, R. V. C. (2021). Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors. ACS Infectious Diseases, 7( 6), 1680-1689. doi:10.1021/acsinfecdis.1c00020

    • NLM

      Okaniwa M, Aguiar ACC, Guido RVC. Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors [Internet]. ACS Infectious Diseases. 2021 ; 7( 6): 1680-1689.[citado 2024 out. 01 ] Available from: https://doi.org/10.1021/acsinfecdis.1c00020

    • Vancouver

      Okaniwa M, Aguiar ACC, Guido RVC. Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors [Internet]. ACS Infectious Diseases. 2021 ; 7( 6): 1680-1689.[citado 2024 out. 01 ] Available from: https://doi.org/10.1021/acsinfecdis.1c00020

  • Artigo de periodico

    Salmonella membrane structural remodeling increases resistance to antimicrobial peptide LL-37 (2019)

    Martynowycz, Michael W.; Rice, Amy; Andreev, Konstantin; Nobre, Thatyane Morimoto; Kuzmenko, Ivan; Wereszczynski, Jeff; Gidalevitz, David

    Source: ACS Infectious Diseases. Unidade: IFSC

    Subjects: BACTÉRIAS GRAM-NEGATIVAS, RESISTÊNCIA MICROBIANA ÀS DROGAS, PEPTÍDEOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MARTYNOWYCZ, Michael W. et al. Salmonella membrane structural remodeling increases resistance to antimicrobial peptide LL-37. ACS Infectious Diseases, v. 5, n. 7, p. 1214-1222, 2019Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.9b00066. Acesso em: 01 out. 2024.

    • APA

      Martynowycz, M. W., Rice, A., Andreev, K., Nobre, T. M., Kuzmenko, I., Wereszczynski, J., & Gidalevitz, D. (2019). Salmonella membrane structural remodeling increases resistance to antimicrobial peptide LL-37. ACS Infectious Diseases, 5( 7), 1214-1222. doi:10.1021/acsinfecdis.9b00066

    • NLM

      Martynowycz MW, Rice A, Andreev K, Nobre TM, Kuzmenko I, Wereszczynski J, Gidalevitz D. Salmonella membrane structural remodeling increases resistance to antimicrobial peptide LL-37 [Internet]. ACS Infectious Diseases. 2019 ; 5( 7): 1214-1222.[citado 2024 out. 01 ] Available from: https://doi.org/10.1021/acsinfecdis.9b00066

    • Vancouver

      Martynowycz MW, Rice A, Andreev K, Nobre TM, Kuzmenko I, Wereszczynski J, Gidalevitz D. Salmonella membrane structural remodeling increases resistance to antimicrobial peptide LL-37 [Internet]. ACS Infectious Diseases. 2019 ; 5( 7): 1214-1222.[citado 2024 out. 01 ] Available from: https://doi.org/10.1021/acsinfecdis.9b00066
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024